Literature DB >> 27393812

The hemodynamic effects of the LVAD outflow cannula location on the thrombi distribution in the aorta: A primary numerical study.

Yage Zhang1, Bin Gao1, Chang Yu2.   

Abstract

Although a growing number of patients undergo LVAD implantation for heart failure treatment, thrombi are still the devastating complication for patients who used LVAD. LVAD outflow cannula location and thrombi generation sources were hypothesized to affect the thrombi distribution in the aorta. To test this hypothesis, numerical studies were conducted by using computational fluid dynamic (CFD) theory. Two anastomotic configurations, in which the LVAD outflow cannula is anastomosed to the anterior and lateral ascending aortic wall (named as anterior configurations and lateral configurations, respectively), are designed. The particles, whose sized are same as those of thrombi, are released at the LVAD output cannula and the aortic valve (named as thrombiP and thrombiL, respectively) to calculate the distribution of thrombi. The simulation results demonstrate that the thrombi distribution in the aorta is significantly affected by the LVAD outflow cannula location. In anterior configuration, the thrombi probability of entering into the three branches is 23.60%, while that in lateral configuration is 36.68%. Similarly, in anterior configuration, the thrombi probabilities of entering into brachiocephalic artery, left common carotid artery and left subclavian artery, is 8.51%, 9.64%, 5.45%, respectively, while that in lateral configuration it is 11.39%, 3.09%, 22.20% respectively. Moreover, the origins of thrombi could affect their distributions in the aorta. In anterior configuration, the thrombiP has a lower probability to enter into the three branches than thrombiL (12% vs. 25%). In contrast, in lateral configuration, the thrombiP has a higher probability to enter into the three branches than thrombiL (47% vs. 35%). In brief, the LVAD outflow cannula location significantly affects the distribution of thrombi in the aorta. Thus, in the clinical practice, the selection of outflow location of LVAD and the risk of thrombi formed in the left ventricle should be paid more attention than before.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  CFD; Heart failure; LVAD; Stroke; Thrombi distribution

Mesh:

Year:  2016        PMID: 27393812     DOI: 10.1016/j.cmpb.2016.05.017

Source DB:  PubMed          Journal:  Comput Methods Programs Biomed        ISSN: 0169-2607            Impact factor:   5.428


  6 in total

1.  Hemodynamic study of the effect of the geometric height of leaflets on the performance of the aortic valve under aortic valve reconstruction.

Authors:  Xinrui Ma; Bin Gao; Liang Tao; Jinli Ding; Shu Li; Aike Qiao; Yu Chang
Journal:  J Thorac Dis       Date:  2022-05       Impact factor: 3.005

Review 2.  Prevention and Treatment of Thrombotic and Hemorrhagic Complications in Patients Supported by Continuous-Flow Left Ventricular Assist Devices.

Authors:  Renzo Y Loyaga-Rendon; Milena Jani; David Fermin; Jennifer K McDermott; Diane Vancamp; Sangjin Lee
Journal:  Curr Heart Fail Rep       Date:  2017-12

3.  The study on hemodynamic effect of series type LVAD on aortic blood flow pattern: a primary numerical study.

Authors:  Qi Zhang; Bin Gao; Yu Chang
Journal:  Biomed Eng Online       Date:  2016-12-28       Impact factor: 2.819

4.  Helical Flow Component of Left Ventricular Assist Devices (LVADs) Outflow Improves Aortic Hemodynamic States.

Authors:  Qi Zhang; Bin Gao; Yu Chang
Journal:  Med Sci Monit       Date:  2018-02-12

Review 5.  Innovative Modeling Techniques and 3D Printing in Patients with Left Ventricular Assist Devices: A Bridge from Bench to Clinical Practice.

Authors:  Rishi Thaker; Raquel Araujo-Gutierrez; Hernan G Marcos-Abdala; Tanushree Agrawal; Nadia Fida; Mahwash Kassi
Journal:  J Clin Med       Date:  2019-05-09       Impact factor: 4.241

6.  The Effects of Left Ventricular Assist Device Support Level on the Biomechanical States of Aortic Valve.

Authors:  Qi Zhang; Bin Gao; Chang Yu
Journal:  Med Sci Monit       Date:  2018-04-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.